Oral liquid hydroxyurea promising for long-term use in babies with sickle cell anemia
HUSOFT extension study at St. Jude shows hydroxyurea is well tolerated in babies, works similarly as in older children, and may prevent sickle cell complications such as organ damage and stunted growth
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.